Review
doi: 10.1016/j.drudis.2007.08.013.
Epub 2007 Oct 23.
Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
Affiliations
- PMID: 18061877
- DOI: 10.1016/j.drudis.2007.08.013
Item in Clipboard
Review
Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
Drug Discov Today.
2007 Dec.
Abstract
Huge amounts of money and knowledge have been poured into biomedical research for decades. Yet, in some disease areas next to no progress has been made in providing medical treatment. Importantly, it is not only neglected diseases where unmet medical need remains, but many diseases of 'rich' countries are also affected. Occasionally, new therapies exacerbate the medical need gap, such as in cancer. Our paper discusses some of the reasons why this might be and why all of society needs to find solutions to address unmet medical need.
Similar articles
-
Converting unmet need for care to effective demand.Int Dent J. 1987 Jun;37(2):114-6. Int Dent J. 1987. PMID: 3476462
-
Government action needed to step up research and development for world's most neglected diseases.Expert Rev Anti Infect Ther. 2005 Dec;3(6):841-3. doi: 10.1586/14787210.3.6.841. Expert Rev Anti Infect Ther. 2005. PMID: 16307495 No abstract available.
-
[The development of the public health system between an increasing market orientation (commercialisation) and social responsibility].Zentralbl Chir. 2008 Feb;133(1):39-45. doi: 10.1055/s-2008-1004667. Zentralbl Chir. 2008. PMID: 18278701 German.
-
Changing roles and responses of health care workers in HIV treatment and care.Trop Med Int Health. 2008 Nov;13(11):1357-63. doi: 10.1111/j.1365-3156.2008.02176.x. Trop Med Int Health. 2008. PMID: 19055620 Review.
-
Involving people affected by cancer in research: a review of literature.Eur J Cancer Care (Engl). 2008 May;17(3):233-44. doi: 10.1111/j.1365-2354.2007.00842.x. Eur J Cancer Care (Engl). 2008. PMID: 18419626 Review.
Cited by
-
A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships.Antiviral Res. 2023 Feb;210:105495. doi: 10.1016/j.antiviral.2022.105495. Epub 2022 Dec 22. Antiviral Res. 2023. PMID: 36567021 Free PMC article. Review.
-
Studying human disease using human neurons.Brain Res. 2017 Feb 1;1656:40-48. doi: 10.1016/j.brainres.2016.03.051. Epub 2016 Apr 6. Brain Res. 2017. PMID: 27060768 Free PMC article. Review.
-
Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline.Front Pharmacol. 2018 Jul 3;9:703. doi: 10.3389/fphar.2018.00703. eCollection 2018. Front Pharmacol. 2018. PMID: 30018554 Free PMC article. Review.
-
The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.Front Med (Lausanne). 2017 Jan 19;3:75. doi: 10.3389/fmed.2016.00075. eCollection 2016. Front Med (Lausanne). 2017. PMID: 28154815 Free PMC article. Review.
-
Getting pharmaceutical R&D back on target.Nat Chem Biol. 2011 Jun;7(6):335-9. doi: 10.1038/nchembio.581. Nat Chem Biol. 2011. PMID: 21587251 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
